New Jersey sues OxyContin maker, links marketing to opioid crisis

This post was originally published on this site

(Reuters) – New Jersey on Tuesday sued Purdue Pharma LP, maker of the chronic pain medication OxyContin, accusing the company of engaging in deceptive marketing practices that contributed to what it called the state’s opioid crisis.